Skip to main content

Prenetics Announces First Quarter 2025 Financial Results, Raises FY2025 Outlook, & Crypto Strategy Announcement Soon

Revenue grew 336.5% to $14.4 million from prior year (excluding ACT Genomics)Raises full year revenue outlook to $80 – $100 million (excluding ACT Genomics)IM8 contributed $5.7 million in Q1, with $2.8 million in March alone & provides Q2 revenue projectionsIM8 has more than 55,000 customers with 4.9 million servings delivered and countingDetails of crypto strategy and Bitcoin adoption to be announced soon as part of innovative treasury approachCHARLOTTE, N.C., June 12, 2025 (GLOBE NEWSWIRE) — Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading health sciences company, today announced unaudited financial results for the first quarter ended March 31, 2025, along with recent business updates. First Quarter 2025 Financial HighlightsRevenue from continuing operations of $17.3 million...

Continue reading

Saratoga Investment Corp. Declares Dividends for the Second Quarter Fiscal 2026 of $0.75 Per Share, In the Aggregate – Paid in a Monthly Dividend of $0.25 Per Share

NEW YORK, June 12, 2025 (GLOBE NEWSWIRE) — Saratoga Investment Corp. (NYSE:SAR) (“Saratoga Investment” or “the Company”), a business development company, today announced that its Board of Directors has declared a base quarterly dividend of $0.75 per share in aggregate for the second quarter of fiscal 2026, declaring the following three monthly dividends for the quarter ended August 31, 2025:Month Amount per Share Record Date Payment DateJune 2025 $0.25 July 8, 2025 July 24, 2025July 2025 $0.25 August 6, 2025 August 21, 2025August 2025 $0.25 September 4, 2025 September 24, 2025“Continuing our strong dividend distribution history and recent monthly payment frequency, our board of directors approved an aggregated dividend for the second quarter of fiscal 2026 of $0.75 per share, paid in monthly dividends of $0.25...

Continue reading

XFC MMA and Roy Jones Boxing Promote Summer Fight Fest Weekend July 11 & 12 at Live! Casino Pittsburgh

Temporary 1,800-seat arena to be built in casino parking lot for exciting two-day eventBoxing legend Roy Jones Jr. to attend both nights HEMPFIELD TWP., Pa., June 12, 2025 (GLOBE NEWSWIRE) — No need to travel this summer to catch some of the best boxing and MMA action. Live! Casino Pittsburgh is bringing the action to you! Live! Casino, along with Xtreme One Entertainment, Inc. (OTC: XONI), parent company of XFC Global, Inc., and legendary world championship boxer and promoter, Roy Jones Jr., are joining forces to present the first-ever Live! Casino Pittsburgh Summer Fight Fest Weekend on Friday, July 11, and Saturday, July 12, unleashing a two-day fight card featuring intense live MMA action and boxing matches. A temporary 1,800-seat arena will be constructed in front of the casino to deliver 14 professional fights over two days...

Continue reading

Sagtec Projects 92% Revenue Growth for FY2025

Accelerating Through AI Robotics Deployment and Platform Expansion Across Asia and the Middle East KUALA LUMPUR, Malaysia, June 12, 2025 (GLOBE NEWSWIRE) — Sagtec Global Limited (NASDAQ: SAGT) (“Sagtec” or the “Company”), a next-generation provider of customizable AI, robotics, and automation platforms, today issued financial guidance for the fiscal year ending December 31, 2025. The Company is forecasting FY2025 revenue of approximately US$22.3 million, a 92% year-over-year increase compared to US$11.6 million in FY2024. This sharp growth trajectory is being driven by robust commercial adoption of Sagtec’s proprietary AI-powered Robotics-as-a-Service (RaaS) and software platforms, which are being deployed across multiple high-growth sectors, including hospitality, logistics, and smart retail. Expansion into underserved markets...

Continue reading

Nasdaq Confirms Full Compliance of HUB Cyber Security with Nasdaq’s Listing Standards

TEL AVIV, Israel, June 12, 2025 (GLOBE NEWSWIRE) — HUB Cyber Security Ltd. (NASDAQ: HUBC) (“HUB” or the “Company”), a global leader in confidential computing and advanced secured data fabric technology, today announced that it is in full compliance with all applicable listing requirements of the Nasdaq Capital Market. Nasdaq has formally confirmed that HUB satisfies both the minimum bid price and the market value of listed securities (MVLS) thresholds under Listing Rules 5550(a)(5) and 5550(b)(2), the “Bid Price” and “MVLS Rules,” respectively. This milestone follows a period of strategic restructuring, improved financial execution, and strengthened corporate governance. Moreover, the Nasdaq Hearings Panel (the “Panel”) has confirmed that HUB has met all exceptions in the Panel’s decision in achieving compliance with the Nasdaq...

Continue reading

Inuvo Reaffirms 25% Q2 YOY Growth Guidance and Completes 1:10 Reverse Stock Split

LITTLE ROCK, Ark., June 12, 2025 (GLOBE NEWSWIRE) — Inuvo, Inc. (NYSE American: INUV), a leading provider of artificial intelligence-driven AdTech solutions, today announced that it was reaffirming its prior guidance that the Company was expecting revenue growth for the second quarter of not less than 25% on a year-over-year basis. The Company also completed a 1-for-10 reverse stock split of its outstanding common stock, as approved by shareholders at the Annual Meeting held on May 22, 2025. Inuvo’s purpose in effectuating the reverse stock split is to improve the marketability and liquidity of its stock aiming to attract a broader range of institutional investors and analysts in support of its long-term growth strategy. Richard Howe, Chief Executive Officer of Inuvo, commented, “Following two consecutive record-breaking quarters,...

Continue reading

ZenaTech’s ZenaDrone to File Patent and Accelerate Deployment of Counter-UAS Technology on the ZenaDrone 1000 in Response to US Executive Order

VANCOUVER, British Columbia, June 12, 2025 (GLOBE NEWSWIRE) — ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) (“ZenaTech”), a technology company specializing in AI (Artificial Intelligence) drone, Drone as a Service (DaaS), enterprise SaaS, and Quantum Computing solutions, today announces its subsidiary ZenaDrone’s intent to file a patent and accelerate the deployment of Counter-Unmanned Aircraft System (Counter-UAS) technology, to be mounted on the company’s flagship ZenaDrone 1000 drone platform in response to a new executive order policy directive. Counter-UAS technology refers to tools or systems that can detect, track, or mitigate unauthorized or dangerous drones to protect people, property, and airspace. ZenaDrone’s technology for this was originally designed last year but was placed on hold as the company...

Continue reading

Carol Clements Appointed to ABM’s Board of Directors

NEW YORK, June 12, 2025 (GLOBE NEWSWIRE) — ABM (NYSE: ABM), a leading provider of facility, engineering, and infrastructure solutions, today announced the appointment of Carol Clements to its Board of Directors. Ms. Clements is a proven technology and digital transformation leader with more than 25 years of experience across the aviation, hospitality, and consulting industries. Ms. Clements currently serves as Chief Digital and Technology Officer at JetBlue Airways Corporation, where she is responsible for the airline’s technology and innovation strategy, and leads the development and implementation of advanced digital solutions that drive operational efficiency and elevate the customer experience. “I’m honored to join ABM’s Board of Directors at such a pivotal moment in the company’s evolution,” said Clements. “ABM is leveraging...

Continue reading

BullFrog AI Announces Strategic Collaboration with Sygnature Discovery to Introduce BullFrog Data Networks™ to Global Biopharma Clients

GAITHERSBURG, Md., June 12, 2025 (GLOBE NEWSWIRE) — BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) (“BullFrog AI” or the “Company”), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced a strategic collaboration with Sygnature Discovery, a leading UK-based contract research organization (CRO) specializing in drug discovery. Through this collaboration, Sygnature will introduce BullFrog Data Networks™—BullFrog’s proprietary AI-driven data insights platform powered by the bfLEAP™ engine—to Sygnature’s global client base of relevant biopharma companies. The collaboration marks a significant commercial milestone for BullFrog AI and is expected to greatly accelerate...

Continue reading

Amneal Receives U.S. FDA Approval for Prednisolone Acetate Ophthalmic Suspension

Key complex product approval in the Affordable Medicines segment this year Commercial launch planned for third quarter of 2025BRIDGEWATER, N.J., June 12, 2025 (GLOBE NEWSWIRE) — Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) today announced the U.S. Food and Drug Administration (FDA) approval of prednisolone acetate ophthalmic suspension, 1% sterile which references Pred Forte®. Pred Forte and its design are trademarks of Allergan, Inc., an AbbVie company. Launch of this product is planned for the third quarter of 2025. Prednisolone acetate ophthalmic suspension, USP 1% is a sterile, topical anti-inflammatory agent for ophthalmic use and is indicated for treating steroid-responsive ocular inflammation. “Our Affordable Medicines portfolio continues to grow with a strong and diverse pipeline that supports broader access...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.